Media

Lupin and Natco Receive Approval from U.S. FDA for Bosentan Tablets for Oral Suspension

Lupin Receives Approval from U.S. FDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03%

Lupin Receives Tentative Approval from U.S. FDA for Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Tablets

Lupin Receives Approval from U.S. FDA for Ipratropium Bromide Nasal Solution (Nasal Spray), 0.06%

Lupin Receives Approval from U.S. FDA for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

Lupin Receives U.S. FDA Approval for Sacubitril and Valsartan Tablets

Lupin Launches Minzoya TM (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the United States

Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Oral Granules

Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin and Saxagliptin Tablets